S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)|
|P||Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)|
|P||Morningstar Stock Analyst Reports (full research on 2,000 stocks)|
|P||Morningstar Stock and Fund Stewardship Grades|
|P||Portfolio Manager (advanced with 10 x-ray analyses, including guidance)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Faruqi & Faruqi, LLP is Investigating Anthera Pharmaceuticals Incorporated on Behalf of its Shareholders - ANTH (2013/2/13)|
|SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Anthera Pharmaceuticals, Inc. in Connection with Executive Compensation (2013/2/13)|
|Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results (2013/3/26)|
|Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study (2013/5/7)|
|Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results (2013/5/13)|
|Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil (2013/2/5)|
|Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock (2013/1/30)|
|Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility (2013/4/5)|
|Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod (2013/3/27)|
|Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus (2013/3/22)|
Click above to view more mutual fund data and stats for anth - Anthera Pharmaceuticals, Inc..